0.318 USD
-0.07 (-18.79%)
0.1748 USD
-0.14 (-45.03%)
Overall HEPA gets a fundamental rating of 1 out of 10. We evaluated HEPA against 190 industry peers in the Pharmaceuticals industry. HEPA may be in some trouble as it scores bad on both profitability and health. HEPA has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- HEPA had negative earnings in the past year.
- In the past year HEPA has reported a negative cash flow from operations.
- HEPA had negative earnings in each of the past 5 years.
- In the past 5 years HEPA always reported negative operating cash flow.
1.2 Ratios
- HEPA has a Return On Assets of -817.53%. This is amonst the worse of the industry: HEPA underperforms 96.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -817.53% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-387.74%
ROA(5y)-247.34%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for HEPA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The number of shares outstanding for HEPA has been reduced compared to 1 year ago.
- Compared to 5 years ago, HEPA has less shares outstanding
- HEPA has a worse debt/assets ratio than last year.
2.2 Solvency
- HEPA has an Altman-Z score of -246.42. This is a bad value and indicates that HEPA is not financially healthy and even has some risk of bankruptcy.
- HEPA has a worse Altman-Z score (-246.42) than 96.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -246.42 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 0.51 indicates that HEPA may have some problems paying its short term obligations.
- Looking at the Current ratio, with a value of 0.51, HEPA is doing worse than 91.92% of the companies in the same industry.
- A Quick Ratio of 0.51 indicates that HEPA may have some problems paying its short term obligations.
- With a Quick ratio value of 0.51, HEPA is not doing good in the industry: 90.40% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.51 | ||
| Quick Ratio | 0.51 |
3. Growth
3.1 Past
- HEPA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.41%.
EPS 1Y (TTM)-4.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- Based on estimates for the next years, HEPA will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.78% on average per year.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y98.11%
EPS Next 2Y41.12%
EPS Next 3Y25.77%
EPS Next 5Y14.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for HEPA. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HEPA. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- HEPA's earnings are expected to grow with 25.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.12%
EPS Next 3Y25.77%
5. Dividend
5.1 Amount
- No dividends for HEPA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
HEPION PHARMACEUTICALS INC / HEPA FAQ
What is the fundamental rating for HEPA stock?
ChartMill assigns a fundamental rating of 1 / 10 to HEPA.
What is the valuation status for HEPA stock?
ChartMill assigns a valuation rating of 1 / 10 to HEPION PHARMACEUTICALS INC (HEPA). This can be considered as Overvalued.
What is the profitability of HEPA stock?
HEPION PHARMACEUTICALS INC (HEPA) has a profitability rating of 0 / 10.
Can you provide the expected EPS growth for HEPA stock?
The Earnings per Share (EPS) of HEPION PHARMACEUTICALS INC (HEPA) is expected to grow by 98.11% in the next year.